Lagahit, Jerly Mae .

HRN: 01-69-54  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2025
CEFUROXIME 1.5GM (VIAL)
04/27/2025
04/30/2025
IV
1.5 G
Q8
Sp 1 LTCS
Waiting Final Action 
04/27/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/27/2025
04/30/2025
IV
500 Mg
Q8
Sp 1 LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: